Stay updated on T-VEC + Pembrolizumab in Sarcoma Clinical Trial
Sign up to get notified when there's something new on the T-VEC + Pembrolizumab in Sarcoma Clinical Trial page.

Latest updates to the T-VEC + Pembrolizumab in Sarcoma Clinical Trial page
- CheckyesterdayChange DetectedThe page revision label was updated from v3.5.4 to v3.5.5. This indicates a new version of the document rather than substantive content changes.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page now shows an updated study protocol revision: v3.5.4, replacing the previous revision v3.5.3. This reflects an updated version of the study-related documents linked to the trial.SummaryDifference0.1%

- Check44 days agoChange DetectedClinicalTrials.gov’s page footer revision tag was updated from v3.5.2 to v3.5.3, indicating a site/version update without changing the study details.SummaryDifference0.1%

- Check51 days agoChange DetectedRevision: v3.5.2 is now shown, replacing the previous Revision: v3.5.0.SummaryDifference0.1%

- Check66 days agoChange DetectedAdded results-related data to the Study Record Dates, including Results First Posted 2025-10-29. Updated associated dates to reflect new published outcomes.SummaryDifference0.1%

- Check80 days agoChange DetectedRevision metadata updated to v3.5.0. The previous v3.4.3 entry was removed.SummaryDifference0.1%

Stay in the know with updates to T-VEC + Pembrolizumab in Sarcoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the T-VEC + Pembrolizumab in Sarcoma Clinical Trial page.